![](/img/cover-not-exists.png)
EFFICACY AND SAFETY OF CONIVAPTAN, A VASOPRESSIN V1A- AND V2-RECEPTOR ANTAGONIST, DURING PHASE 3 TRIALS OF PATIENTS WITH EUVOLEMIC OR HYPERVOLEMIC HYPONATREMIA
Verbalis, Joseph G., Rosansky, Steven, Wagoner, Lynne E., McNutt, Bruce, Yan, BoVolume:
132
Language:
english
Journal:
Chest
DOI:
10.1378/chest.132.4_meetingabstracts.562b
Date:
October, 2007
File:
PDF, 273 KB
english, 2007